Cytek Biosciences, Inc. CTKB Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$74M— | -$66.54M— | —— | —— | —— | ||
| $7.57M+2.4% | $7.58M+5.1% | $7.54M+7.8% | $7.47M+8.2% | $7.39M+9.5% | ||
| $22.82M-18.0% | $24.59M-8.4% | $26.06M+2.1% | $27.48M+13.4% | $27.84M+21.1% | ||
| -$7.41M-135% | -$4.79M-119% | -$2.03M-106% | $15.09M-2.2% | $21.3M— | ||
| $5.4M+41.9% | $4.08M+15.9% | $3.98M-3.7% | $4.33M-2.7% | $3.81M-19.2% | ||
| —— | —— | -$51.47M— | -$86.2M— | -$69.79M— | ||
| —— | —— | —— | $34.09M-25.4% | $32.25M— | ||
| $9.96M+186% | $5.58M+33.4% | $6.95M+397% | $4.87M+249% | $3.48M+150% | ||
| $4.1M+112% | $4.75M+752% | $1.94M+248% | $1.94M+249% | $1.94M+247% | ||
| —— | —— | —— | -$29.87M+29.1% | -$28.98M+27.9% | ||
| —— | —— | —— | -$102.45M— | -$73.84M— | ||
| -$12.7M-173% | -$8.77M-140% | -$5.9M-120% | $10.87M-1.0% | $17.49M+947% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cytek Biosciences, Inc. generate?
- Cytek Biosciences, Inc. (CTKB) generated -$7.4M in operating cash flow over the trailing twelve months.
- What is Cytek Biosciences, Inc.'s free cash flow?
- After $5.4M of capital expenditures, Cytek Biosciences, Inc.'s free cash flow was -$12.7M over the trailing twelve months, down 172.6% year over year.
- Where does Cytek Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Cytek Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
